1
EXHIBIT 10.43
PARACELSUS HEALTHCARE CORPORATION
EMPLOYMENT AGREEMENT
AGREEMENT, dated as of July 17, 1996, between Paracelsus Healthcare
Corporation, a California corporation (the "Company"), and Charles R. Miller
(the "Executive").
In consideration of the premises and the respective covenants and
agreements of the parties herein contained, and intending to be legally bound
hereby, the parties agree as follows:
1. EMPLOYMENT. The Company hereby agrees to employ the Executive and
the Executive hereby agrees to serve the Company, on the terms and conditions
set forth herein. In addition, the Executive and the Company hereby agree that
subject to and effective as of the closing of the proposed merger transaction
among the Company, Champion Healthcare Corporation, a Delaware corporation
("Champion"), and PC Merger Sub, Inc., a Delaware corporation and a wholly
owned subsidiary of the Company ("PC Merger Sub"), whereby Champion will become
a wholly owned subsidiary of the Company (the "Merger"), this Agreement shall
supersede that certain employment agreement (the "Prior Agreement") between the
Company and the Executive, dated as of August 4, 1995.
2. TERM OF EMPLOYMENT; DUTIES. From the period commencing on the date
hereof and ending immediately prior to the Effective Time (as defined in the
Agreement and Plan of Merger by and among the Company, Champion and PC Merger
Sub dated as of April 12, 1996, as amended May 29, 1996, and as such agreement
may be amended from time to time (the "Merger Agreement")), the employment of
the Executive shall be governed by the terms and conditions set forth in the
Prior Agreement. The term of this Agreement (the "Term"), and Executive's
employment with the Company hereunder, shall commence at the Effective Time
and, unless earlier terminated in accordance with the terms hereof, shall
continue until the fifth anniversary of the Effective Time (such initial term
of the Agreement referred to as the "Initial Term"); PROVIDED, HOWEVER, that
the Term shall automatically be renewed for an additional period of five years
(each such period, a "Renewal Period") at the end of the Initial Term and at
the end of each Renewal Period, if any, unless either the Company or the
Executive provides at least one year's notice to the other of its intention not
to renew the Term; and PROVIDED, FURTHER, that if the Merger Agreement is
terminated in accordance with its terms prior to the Effective Time or if the
Merger is abandoned or otherwise does not close, (x) this Agreement shall
automatically terminate without further obligation by either party hereto, (y)
the terms and conditions set forth in this Agreement shall not apply and (z)
the employment of the Executive shall continue to be governed by the terms and
conditions set forth in the Prior Agreement.
2
During the Term, the Executive shall be employed as the President and
Chief Operating Officer of the Company serving at the will of the Board of
Directors of the Company (the "Board") with, subject to the express terms and
conditions hereof, the traditional duties, responsibilities and authority of
such office in companies similar in size to the Company. The Executive agrees
that he shall perform his duties hereunder faithfully and to the best of his
abilities and in furtherance of the business of the Company and its
subsidiaries and shall devote substantially all of his business time, energy
and attention to the business of the Company and its subsidiaries. The
Executive shall agree to serve and the Company shall use its best efforts to
nominate and cause the Executive to be elected as a member of the Board. In
addition, for so long as Executive shall serve as a member of the Board, he
shall agree to serve as and the Company shall use its best efforts to nominate
and cause the Executive to be elected as a member of the Executive Committee of
the Board ("Executive Committee").
The Executive agrees to use his authorities as President and as a member
of the Board and of the Executive Committee to manage and cause others to
manage the Company in accordance with the management guidelines set forth on
Exhibit A hereto; PROVIDED, HOWEVER, that nothing in this Section shall require
the Executive to violate or breach his duties under the law of the state of
incorporation of the Company or any other applicable laws. The Company agrees
to use its best efforts to manage and cause others to manage the Company in
accordance with the management guidelines set forth in Exhibit A hereto.
3. COMPENSATION AND RELATED MATTERS.
(a) BASE SALARY. During the Term, the Company shall pay to the
Executive an annual base salary (the "Base Salary") at an initial rate of
$500,000 per year, payable in accordance with the Company's normal payroll
practices or as the Company and Executive may otherwise agree. The Base Salary
shall be reviewed by the Company annually and shall be subject to discretionary
increase by the Company from time to time, but shall not be decreased from the
rate in effect at any time and from time to time during the Term.
(b) ANNUAL PERFORMANCE BONUS. Executive shall be entitled to
participate in the Paracelsus Healthcare Corporation Executive Officer
Performance Bonus Plan or any similar or successor annual bonus plan of the
Company (the "Performance Bonus Plan") and to receive an annual performance
bonus upon the achievement of one or more annual performance goals (the
"Performance Goals") in accordance with the terms of the Performance Bonus
Plan; PROVIDED, that Executive's annual target bonus under the Performance
Bonus Plan (the
3
"Annual Target Bonus") shall not be less than 85% of the Base Salary in effect
at the time the Performance Goals for such plan year are established.
(c) LONG-TERM INCENTIVE. The Executive shall be eligible to
participate in any long-term incentive compensation and/or stock option plans
maintained from time to time by the Company. In addition, pursuant to prior
action of the Stock Option Committee of the Board, Executive has previously
been granted (i) options (the "Value Options") to purchase 336,000 shares of
Company common stock, no stated par value (the "Common Stock"), at an exercise
price of $.01 per share with a term of 10 years from the date of grant and (ii)
an option (the "Market Option") to purchase an additional 1,000,000 shares of
Common Stock at an exercise price equal to the fair market value (as defined in
the Paracelsus Healthcare Corporation 1996 Stock Incentive Plan (the "1996
Stock Incentive Plan")) of the Common Stock on the date of the Effective Time
with a term of 10 years from the date of grant. The Value Options will be
fully vested on grant and will become fully exercisable at the Effective Time,
and the Market Option will generally vest and become exercisable in equal
annual installments of 25% on each of the first four anniversaries of the
Effective Time; PROVIDED, that neither the Value Options nor the Market Option
will become exercisable in whole or in part in the event the Merger Agreement
is terminated in accordance with its terms prior to the Effective Time or if
the Merger is abandoned or otherwise does not close; and PROVIDED, FURTHER,
that the Value Options and the Market Option shall each be subject to the terms
of the 1996 Stock Incentive Plan and the stock option agreements to be entered
into in connection with the grant of such options.
(d) BENEFITS, PERQUISITES AND EXPENSES. During the Term, the
Executive shall be eligible to participate in employee benefit and fringe
benefit plans and programs generally available to the executive officers of the
Company and such additional benefits as the Board may from time to time
provide. In addition, Executive shall be entitled to receive the personal
benefits described in Exhibit B hereto. Reimbursement for business expenses,
including travel and entertainment shall be limited to reasonable and necessary
expenses incurred by the Executive in connection with the performance of duties
on behalf of the Company subject to: (i) timely submission of a properly
executed Company expense report form accompanied by appropriate supporting
documentation, and (ii) compliance with Company policies and procedures
governing business expense reimbursement and reporting based upon principles
and guidelines established by the Audit Committee of the Board, including
periodic audits by the Internal Audit Department of the Company and/or the
Audit Committee.
(e) RETIREMENT BENEFITS. Effective as of the Effective Time of
the Merger, the Executive shall be entitled to participate in
4
the Paracelsus Healthcare Corporation Supplemental Executive Retirement Plan or
any similar or successor plan (the "SERP") and in any tax-qualified and any
other supplemental pension plans generally available to the executive officers
of the Company; PROVIDED, that employment with Champion and its subsidiaries
shall be taken into account for purposes of eligibility, vesting and benefit
accrual under the SERP, but not for purposes of determining whether a
"Post-Participation Change in Control", as defined in the SERP, has occurred.
(f) SIGN-ON BONUS. In connection with the commencement of the
Executive's employment with the Company, as soon as practicable after the
Effective Time, the Company shall provide the Executive a lump sum cash payment
in the amount of $1,200,000.
4. TERMINATION OF EXECUTIVE. Prior to the expiration of the Term and
subject to the payment of any amounts required under Section 5, the Executive's
employment with the Company may be terminated (a) by the Company with or
without Cause, (as defined below), PROVIDED that no less than 80% of the then
members of the Board (excluding, for the purposes of such calculation, the
Executive) and no less than 2/3 of the Independent Directors (as defined in the
Shareholder Agreement of the Company to be entered into in connection with the
Merger (the "Shareholder Agreement")) have approved such termination, (b) by
the Executive for or without Good Reason (as defined herein), (c) by reason of
the Executive's death or Disability (as defined herein) or (d) by the mutual
written consent of the parties hereto. For purposes of this Agreement:
(i) "Cause" means (A) acts of embezzlement, theft and fraud
established by a preponderance of the evidence; (B) actions which have had or
will likely have a material adverse financial effect on the Company as a whole
for an extended period of time, where appropriate evidence exists that such
actions are directly attributable to the (I) gross management negligence or
repeated ineptitude of the Executive and/or (II) deliberate refusal of the
Executive to follow the instructions or directions of the Board; (C) conviction
of or a plea of guilty or NOLO CONTENDERE to a felony; (D) violation of the
noncompete or confidentiality provisions of this Agreement, PROVIDED, that no
such violation will be deemed to have occurred if, within 30 days following
receipt by Executive of a notice from the Board identifying the violation, the
Executive (I) cures the violation and (II) establishes that the violation was
unintentional and not reasonably likely to result in harm to the Company, in
each case to the reasonable satisfaction of the Board; (E) material
incapacitation or repeated absence from work due to reckless and self-abusive
behavior or conduct, such as alcoholism and drug abuse, which renders Executive
incapable of performing his duties; PROVIDED, that physical or mental
disability due to injury or disease shall not be
5
grounds for termination for Cause; (F) material repeated incompetence in
performing the duties of the Executive's office, PROVIDED, that such
incompetence is: (I) supported by written documentation of such incompetence,
(II) occurs after the Executive has been previously counseled by the Board both
orally and in writing with respect to specific examples of such incompetence
and has been provided the opportunity to respond in kind, and (III) determined
to be incurable and to be of such a nature as to have had or which would have
been reasonably likely at the time of such commission to have a material
adverse effect on the Company as a whole; or (G) a material violation by the
Executive of the provisions set forth in Exhibit A hereto; PROVIDED, that the
Company provides the Executive with notice of such violation within 30 days of
its discovery of such violation and the Executive fails to cure such breach to
the reasonable satisfaction of the Board within 10 days of receipt of such
notice.
For purposes of this Agreement, the Board shall have 60 days to terminate
the Executive for Cause following the date on which the Board discovers the
existence of a specific set of facts that, in the aggregate, then constitute
Cause, after which period no Cause with respect to such specific set of facts
shall be deemed to exist; PROVIDED, that the repetition or reoccurrence of the
same or a similar set of facts shall constitute a separate ground for
termination for Cause.
(ii) "Disability" means the Executive's absence from the full-time
performance of his duties with the Company for one hundred eighty (180) days or
more within any period of 12 consecutive months as a result of the Executive's
incapacity due to mental or physical illness; PROVIDED, that during any period
prior to the termination of Executive's employment by reason of Disability in
which Executive is absent from the full-time performance of his duties with the
Company due to Disability, the Company shall continue to pay Executive his Base
Salary at the rate in effect at the commencement of such period of Disability;
(iii) "Good Reason" means, without the Executive's express written
consent, the occurrence of any of the following events:
(A) a reduction by the Company in the Executive's Base Salary
or Annual Target Bonus in effect from time to time; (B) a material reduction in
the aggregate level of participation in and/or compensation and benefit
opportunities under all other compensation and employee benefit plans in which
Executive is entitled to participate from time to time; PROVIDED, HOWEVER, that
changes affecting the participation in or benefits under such plans (other than
the Performance Bonus Plan, the SERP and the benefits described in Exhibit B)
with respect to similarly situated Executives of the Company shall not
constitute Good Reason hereunder; (C) a reduction in
6
the Executive's titles, duties or authority with the Company or a material
adverse change in Executive's reporting relationships; (D) the relocation of
the principal executive offices of the Company to a location that increases the
Executive's one-commute thereto by more than 25 miles; (E) the Executive no
longer reports to Mr. Messenger or, in the event that Mr. Messenger ceases to
be the Chief Executive Officer of the Company ("CEO"), the failure of the Board
to appoint the Executive as CEO; (F) notification by the Company of its
intention not to renew this Agreement pursuant to the provisions of Section 2;
(G) the failure of the Executive to be nominated for election to and elected to
serve as a member of the Board or, for so long as he is a member of the Board
or, for so long as he is a member of the Board, to be appointed to the
Executive Committee; (H) the termination of the Executive's employment by the
Executive for any reason within 12 months following a Change in Control (as
defined herein); or (I) failure of the Company, Dr. Manfred G. Krukemeyer or
Mr. Messenger to comply with any of the provisions set forth in Exhibit A
hereto, without regard to whether such terms are enforceable, which is not
cured by the Company, Dr. Krukemeyer or Mr. Messenger, as applicable, within 30
days of its or his receipt of a notice specifying the manner in which the
Company, Dr. Krukemeyer and/or Mr. Messenger is failing or has failed to comply
with the applicable provisions set forth in Exhibit A hereto.
(iv) "Change in Control" means the occurrence of any one of the
following events:
(A) any "person" (as such term is defined in Section 3(a)(9)
of the Securities Exchange Act of 1934 (the "Exchange Act") and as used in
Sections 13(d)(3) and 14(d)(2) of the Exchange Act) becomes an Acquiring Person
(as such term is defined in the Company's Shareholder Protection Rights
Agreement to be adopted at the Effective Time) or any person that is not bound
by the Shareholder Agreement becomes the "beneficial owner" (as defined in Rule
13d-3 under the Exchange Act), directly or indirectly, of securities of the
Company representing 25% or more of the undiluted total voting power of the
Company's then outstanding securities eligible to vote for the election of
members of the Board (the "Company Voting Securities"); PROVIDED, HOWEVER, that
no event described in the immediately preceding clause shall be deemed to
constitute a Change in Control by virtue of any of the following: (I) an
acquisition of Company Voting Securities by the Company and/or one or more
direct or indirect majority-owned subsidiaries of the Company; (II) an
acquisition of Company Voting Securities by any employee benefit plan sponsored
or maintained by the Company or any corporation controlled by the Company;
(III) an acquisition by any underwriter temporarily holding securities pursuant
to an offering of such securities; or (IV) any acquisition by the Executive or
any "group" (as such term is defined
7
in Rule 3d-5 under the Exchange Act) of persons including the Executive; or
(B) individuals who, at the beginning of any period of
twenty-four (24) consecutive months, constitute the Board (the "Incumbent
Board") cease for any reason to constitute at least a majority thereof;
PROVIDED, HOWEVER, that any person becoming a director subsequent to the
beginning of such twenty-four (24) month period, whose election, or nomination
for election, by the Company's shareholders was approved by either (i) the
Board consistent with the terms of the Shareholder Agreement, during the period
the Shareholder Agreement is in effect, or (ii) a vote of at least 75% of the
directors comprising the Incumbent Board (either by a specific vote or by
approval of the proxy statement of the Company in which such person is named as
a nominee for director, without objection to such nomination) shall be, for
purposes of this paragraph (B), considered as though such person were a member
of the Incumbent Board; PROVIDED, FURTHER, that no individual initially elected
or nominated as a director of the Company as a result of an actual or
threatened election contest with respect to directors or any other actual or
threatened solicitation of proxies or consents by or on behalf of any person
other than the Board shall be deemed to be a member of the Incumbent Board; or
(C) there is consummated a merger or consolidation of the
Company or a subsidiary thereof with or into any other corporation other than a
merger or consolidation which would result in the holders of the voting
securities of the Company outstanding immediately prior thereto holding
securities which, in combination with the ownership of any trustee or other
fiduciary holding securities under an employee benefit plan of the Company,
represent immediately after such merger or consolidation at least 60% of the
combined voting power of the then outstanding voting securities of either the
Company or the other entity which survives such merger or consolidation or any
parent of such other entity; or
(D) the stockholders of the Company approve (i) a plan of
complete liquidation or dissolution of the Company or (ii) an agreement for the
sale or disposition by the Company of all or substantially all the Company's
assets.
5. PAYMENTS UPON TERMINATION OF EXECUTIVE
If the employment of the Executive shall be terminated other than by
reason of death or Disability (i) by the Company (other than for Cause) or (ii)
by the Executive for Good Reason, then the Company shall pay or provide to the
Executive (or the Executive's beneficiary or estate):
8
(1) within thirty (30) days following the date of such termination
of employment ("Termination Date"), a lump-sum cash amount equal to the sum of
(i) the Executive's unpaid Base Salary through the Termination Date; (ii) any
accrued but unpaid annual bonus under the Performance Bonus Plan in respect of
the annual bonus period preceding the bonus period in which the Termination
Date occurs; (iii) any unpaid reimbursable business expenses properly incurred
through the Termination Date; and (iv) a bonus payment equal to the Executive's
Annual Target Bonus in the year of termination, multiplied by a fraction the
numerator of which is the number of months in the bonus year of termination in
which the Executive has worked at least one day and the denominator of which is
12;
(2) within thirty (30) days following the Termination Date, a
lump-sum cash amount equal to the greater of (A) the Executive's then Base
Salary payable over the remainder of the Term plus a bonus equal to the
Executive's Annual Target Bonus in the year of termination multiplied by a
fraction the numerator of which is the number of complete months remaining in
the Term and the denominator of which is 12, or (B) 3.0 times the sum of: (i)
the Executive's annual rate of Base Salary as of the Termination Date plus (ii)
the Annual Target Bonus for the year in which the Termination Date occurs (in
each such case, Executive's Base Salary and Annual Target Bonus being
determined without taking into account any reductions thereto constituting Good
Reason); PROVIDED, HOWEVER, that the Executive shall not be entitled to any
severance benefits from the Company or under any Company severance plan, policy
or arrangement other than as specified in this Agreement;
(3) for a period terminating on the earlier of (A) the
commencement of the provision of substantially equivalent benefits by a new
employer or (B) the later of (I) the last day of the Term, or (II) thirty-six
(36) months following the Termination Date, the Company shall continue to keep
in full force and effect (or otherwise provide) all policies of medical,
accident, disability and life insurance with respect to the Executive and his
dependents with substantially the same level of coverage, upon substantially
the same terms and otherwise substantially to the same extent as such policies
shall have been in effect immediately prior to the Termination Date, and, as
applicable, the Company and the Executive shall share the costs of the
continuation of such insurance coverage in the same proportion as such costs
were shared immediately prior to the date of termination;
(4) for purposes of determining final average compensation (or making
any similar calculation) and years of service (for purposes of eligibility,
vesting and benefit accrual) under any tax-qualified or supplemental defined
benefit retirement plan (including without limitation the SERP), Executive
shall be deemed to have remained
9
employed by the Company hereunder until the end of the Term and to have
received his then current Base Salary and Annual Target Bonus through the end
of the Term; PROVIDED, that to the extent such benefits cannot be accrued under
and paid from any tax-qualified pension plan, such benefits shall be accrued
under and paid from the SERP or other supplemental plan.
(5) all options to purchase Common Stock held by the Executive shall
immediately become fully vested and exercisable and shall remain exercisable
until the earlier of (A) the date that is 24 months following the Termination
Date and (B) the expiration of the stated term of such options; PROVIDED, that
the Value Options shall remain exercisable until expiration of their stated
term; and
(b) If the employment of the Executive shall be terminated (i) by reason
of the Executive's death or Disability, (ii) by the Company for Cause, (iii) by
the Executive without Good Reason, or (iv) by the mutual written consent of the
parties hereto (each a "Nonqualifying Termination"), then the Company shall pay
to the Executive (or the Executive's beneficiary or estate) within thirty (30)
days following the Termination Date a lump-sum cash amount equal to the sum of
the Executive's unpaid Base Salary through the Termination Date plus any bonus
payments which have been earned or become payable, to the extent not
theretofore paid, plus any unpaid reimbursable business expenses properly
incurred through the Termination Date. In addition, Executive (or the
Executive's beneficiary or estate) shall have no less than ninety days
following the termination of his employment pursuant to a Nonqualifying
Termination to exercise any outstanding options to the extent vested and
exercisable as of the Termination Date; PROVIDED, that the Value Options shall
remain exercisable until the expiration of their stated term.
6. CERTAIN ADDITIONAL PAYMENTS BY THE COMPANY.
(a) Notwithstanding anything in this Agreement to the contrary, in
the event that any payment or distribution by the Company, by any affiliate of
the Company or by any person whose actions result in a Change in Control of the
Company (to the extent the Company approves of the arrangements pursuant to
which the payment by such person is made to the Executive) to or for the
benefit of the Executive (whether paid or payable or distributed or
distributable pursuant to the terms of this Agreement or otherwise, but
determined without regard to any additional payments required under this
Section 6) (a "Payment") would be subject to the excise tax imposed by Section
4999 of the Code, or any interest or penalties are incurred by the Executive
with respect to such excise tax (such excise tax, together with any such
interest and penalties, are hereinafter collectively referred to as the "Excise
Tax"), then the Executive shall be entitled to receive an additional payment (a
"Gross-Up Payment") in an amount
10
such that, after payment by the Executive of all taxes (including any interest
or penalties imposed with respect to such taxes) including, without limitation,
any income and employment taxes and Excise Tax, imposed upon the Gross-Up
Payment but before deduction for any federal, state or local income or other
tax upon the Payments, the Executive will retain a net amount equal to the sum
of (i) the Payments and (ii) an amount equal to the product of any deductions
(or portion thereof) disallowed because of the inclusion of the Gross-Up
Payment in the Executive's adjusted gross income for federal income tax
purposes and the highest applicable marginal rate of federal income taxation
for the calendar year in which the Gross-Up Payment is to be made. For
purposes of determining the amount of the Gross-Up Payment, the Executive shall
be deemed to (1) pay applicable federal income taxes at the highest applicable
marginal rates of federal income taxation (including surcharges) for the
calendar year in which the Gross-Up Payment is to be made, (2) pay applicable
state and local income taxes at the highest applicable marginal rate of
taxation (including surcharges) for the calendar year in which the Gross-Up
Payment is to be made, net of the maximum reduction in federal income taxes
which could be obtained from deduction of such state and local taxes and (3)
have otherwise allowable deductions for federal income tax purposes at least
equal to those disallowed because of the inclusion of the Gross-Up Payment in
the Executive's adjusted gross income.
(b) Subject to the provisions of Section 6(a), all determinations
required to be made under this Section 6, including whether and when a Gross-Up
Payment is required and the amount of such Gross-Up Payment and the assumptions
to be utilized in arriving at such determination, shall be made by the public
accounting firm that is retained by the Company as of the date immediately
prior to the Change in Control (the "Accounting Firm") which shall provide
detailed supporting calculations both to the Company and the Executive within
fifteen (15) business days of the receipt of notice from the Company or the
Executive that there has been a Payment, or such earlier time as is requested
by the Company (collectively, the "Determination"). In the event that the
Accounting Firm is serving as accountant or auditor for the individual, entity
or group effecting the Change in Control, the Executive may appoint another
nationally recognized public accounting firm reasonably acceptable to the
Company to make the determinations required hereunder (which accounting firm
shall then be referred to as the Accounting Firm hereunder). All reasonable
fees and expenses of the Accounting Firm shall be borne solely by the Company
and, subject to applicable law and obligations to the Company's stockholders,
the Company shall enter into any agreement reasonably requested by the
Accounting Firm that is generally recognized as standard in connection with the
performance of the services hereunder. The Gross-Up Payment under this Section
6 with respect to any Payment shall be made no later than thirty (30) days
11
following the date of such payment. If the Accounting Firm determines that no
Excise Tax is payable by the Executive, it shall furnish the Executive with a
with a written opinion to such effect, and to the effect that failure to report
the Excise Tax, if any, on the Executive's applicable federal income tax return
should not result in the imposition of a negligence or similar penalty. The
Determination by the Accounting Firm shall be binding upon the Company and the
Executive. As a result of uncertainty in the application of Section 4999 of
the Code at the time of the Determination, it is possible that Gross-Up
Payments which will not have been made by the Company should have been made
("Underpayment") or Gross-Up Payments are made by the Company which should not
have been made ("Overpayment"), consistent with the calculations required to be
made hereunder. In the event that the Executive thereafter is required to make
payment of any additional Excise Tax, the Accounting Firm shall determine the
amount of the Underpayment that has occurred and any such Underpayment
(together with interest at the rate provided in Section 1274(b)(2)(B) of the
Code) shall be promptly paid by the Company to or for the benefit of the
Executive. In the event the amount of the Gross-Up Payment exceeds the amount
necessary to reimburse the Executive for his Excise Tax, the Accounting Firm
shall determine the amount of the Overpayment that has been made and any such
Overpayment (together with interest at the rate provided in Section 1274(b)(2)
of the Code) shall be promptly paid by the Executive to or for the benefit of
the Company. The Executive shall cooperate, to the extent his reasonable
expenses in connection therewith are reimbursed by the Company, with any
reasonable requests by the Company in connection with any contests or disputes
with the Internal Revenue Service in connection with the Excise Tax.
7. WITHHOLDING TAXES. The Company shall have the right to withhold from
any and all payments due to the Executive (or his beneficiary or estate)
hereunder all taxes which, by applicable federal, state, local or other law,
the Company is required to withhold therefrom.
8. SUCCESSORS; BINDING AGREEMENT
(a) This Agreement is personal in nature and none of the parties
hereto shall, without the consent of the other, assign, or transfer this
Agreement or any rights or obligations hereunder; PROVIDED, that in the event
of the merger, consolidation, transfer or sale of substantially all of the
assets of the Company with or to any other individual or entity, this Agreement
shall, subject to the provisions hereof, be binding upon and inure to the
benefit of such successor and such successor shall discharge and perform all
the promises, covenants, duties and obligations of the Company hereunder, and
all references herein to the "Company" shall refer to such successor.
12
(b) This Agreement shall inure to the benefit of and be
enforceable by the Executive's personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees. If the
Executive shall die while any amounts remain payable to the Executive
hereunder, all such amounts, unless otherwise provided herein, shall be paid in
accordance with the terms of this Agreement to such person or persons appointed
in writing by the Executive to receive such amounts or, if no person is so
appointed, to the Executive's estate.
9. RESOLUTION OF DISPUTES; LEGAL FEES; NO MITIGATION
(a) Except as provided in Sections 10 and 11, all disputes
hereunder shall be settled by final, binding arbitration, conducted before a
panel of three (3) arbitrators in Texas in accordance with the rules of the
American Arbitration Association then in effect. Judgment on the arbitration
award may be entered in any court having jurisdiction. The Company shall bear
the expenses of such arbitration.
(b) If any contest or dispute shall arise under this Agreement
involving termination of the Executive's employment with the Company or
involving the failure or refusal of the Company to perform fully in accordance
with the terms hereof, the Company shall advance and reimburse the Executive,
on a current basis, all legal fees and expenses, if any, incurred by the
Executive in connection with such contest or dispute; PROVIDED, that the
Executive agrees to return any advanced or reimbursed expenses to the extent
the arbitrators (or the court, in the case of a dispute described in Section 10
or 11) determine that the Company has prevailed as to the material issues
raised in determination of the dispute.
(c) The Company's obligation to make any payments provided for in
this Agreement to the Executive and otherwise to perform its obligations
hereunder shall not be affected by any setoff, counterclaim, recoupment,
defense or other claim, right or action which the Company may have against the
Executive or others. In no event shall the Executive be obligated to seek
other employment or take other action by way of mitigation of the amounts
payable to the Executive under any of the provisions of this Agreement, and
such amounts shall not be reduced whether or not the Executive obtains other
employment.
10. NONCOMPETITION
(a) DISCLOSURE. The Executive has disclosed to the Board, in
writing, all healthcare-related interests, investments, or business activities,
whether as proprietor, stockholder, partner, co-venturer,
13
director, officer, employee, independent contractor, agent, consultant, or in
any other capacity or manner whatsoever. The Executive shall promptly notify
the Board, in writing, of any changes in or additions to such interests,
activities or investments permitted in accordance with the terms of this
Agreement, within 15 days of such change or addition.
(b) PROHIBITED ACTIVITY. Without the written consent of a
majority of the Independent Directors, the Executive may not engage in any of
the following actions during the period that is (A) prior to the Executive's
termination of employment with the Company, (B) within two years following the
termination of his employment with the Company during the Initial Term if such
termination is by the Company for Cause or by the Executive other than for Good
Reason and (C) within one year following his termination of employment during
the Term but after the Initial Term if such termination is by the Company for
Cause or by the Executive other than Good Reason.
(i) own, either directly or indirectly, any interest in any
business that competes with the "Primary Business" in which the Company or any
subsidiary or affiliate is engaged, within a radius of 30 miles from any site,
facility, or location which is owned, managed or operated by or affiliated with
the Company or any of its subsidiaries and affiliates, including physician
practices of any kind. For purposes of this Agreement, "Primary Business"
shall mean the delivery of integrated healthcare services in markets where the
Company or its subsidiaries own hospitals and/or skilled nursing facilities
("SNFs") with the hospital serving as the hub of the local delivery system in
conjunction with its physician medical staff. In addition to inpatient acute
care, psychiatric care, and skilled nursing care, these services can include
(A) individual physician practices and/or physician-based organizations such as
primary care and specialty clinics, physician-hospital organizations ("PHOs")
or medical service organizations ("MSOs"), or physician medical groups and (B)
ambulatory programs such as home health care, ambulatory surgery, psychiatric
services, occupational and sports medicine centers, psychiatric after-care and
day care programs, and other diagnostic, rehabilitative and treatment services.
Some of these services, sites and facilities may be located in satellite areas
for the purpose of extending the hub hospital's geographic service area and to
serve as access points and/or referral sources for either the local delivery
system or the hub hospital's geographic service area and to serve as access
points and/or referral sources for either the local delivery system or the hub
hospital. The Board may modify, from time to time, the definition of Primary
Business to include any additional business or service activity in which the
Company may engage during the Term or to exclude any business or service in
which the Company ceases to engage. The definition of "Primary Business" may
also be modified to include any business or service into which, as
14
of the Termination Date, the Company definitively intends to expand, regardless
of whether such expansion actually occurs after the Executive's termination.
For purposes of the preceding sentence, the date on which a modification of the
definition of "Primary Business" shall be effective shall be the date on which
the Executive is provided written notice of such modification (the "Notice
Date"); PROVIDED, HOWEVER, that no such modification as to which notice is
provided on or after the Termination Date shall be effective against the
Executive; and PROVIDED, FURTHER, that no such modification shall be effective
with respect to any interests, investments or business activities engaged in by
Executive prior to the Notice Date of such modification and properly disclosed
prior to such Notice Date pursuant to Section 10(a);
(ii) participate or serve, either directly or indirectly,
whether as a proprietor, stockholder, partner, co-venturer, director, officer,
employee, independent contractor, agent, consultant, or in any other capacity
or manner whatsoever in any business or service activity that competes with the
Primary Business;
(iii) directly or indirectly, solicit or recruit any
individual employed by the Company, its subsidiaries or affiliates for the
purpose of being employed by him or by any competitor of the Company on whose
behalf he is acting as an agent, representative or employee, or convey any
confidential information or trade secrets regarding other employees of the
Company, its subsidiaries or affiliates to any other person; or
(iv) directly or indirectly, influence or attempt to
influence customers of the Company or any of its subsidiaries or affiliates to
direct their business to any competitor of the Company;
PROVIDED, HOWEVER, that neither (i) the "beneficial ownership" by Executive,
either individually or as a member of a "group," as such terms are used in Rule
13d under the Exchange Act, as a passive investment, of not more than five
percent (5%) of the voting stock of any publicly held corporation, nor (ii) the
beneficial ownership by Executive of any interest described in the first
sentence of Section 10(a) and properly and timely disclosed in accordance with
the terms therewith, shall alone constitute a violation of this Agreement.
In the event that the Executive engages in the conduct proscribed by
this Section 10, the Executive agrees to repay any lump-sum severance amount
received pursuant to Section 5 of this Agreement, and all outstanding stock
options held by the Executive shall expire as of the date of the Executive's
commencement of such proscribed conduct. It is further expressly agreed that
the Company will or would suffer irreparable injury if Executive were to
compete with the Company or any subsidiary or affiliate in violation of this
Agreement
15
and that the Company would by reason of such competition be entitled to
preliminary or injunctive relief in a court of appropriate jurisdiction, and
Executive further consents and stipulates to the entry of such preliminary or
injunctive relief in such a court prohibiting Executive from competing with the
Company or any subsidiary or affiliate of the Company in violation of this
Agreement upon an appropriate finding by such court that Executive has violated
this Section 10.
(c) UNENFORCEABLE PROVISIONS. It is the desire and the intent of
the parties that the provisions of this Section 10 shall be enforceable to the
fullest extent permissible under applicable law and public policy.
Accordingly, if this Section 10 or any portion thereof shall be adjudicated to
be invalid or unenforceable whether because of the duration and scope of the
covenants set forth herein or otherwise, the length and scope of the
restrictions set forth in this Section 10 shall be reduced to the extent
necessary so that this covenant may be enforced to the fullest extent possible
under applicable law.
11 CONFIDENTIAL INFORMATION. The Executive acknowledges that in his
employment hereunder, and during prior periods of employment with the Company
and/or its subsidiaries, he has occupied and will continue to occupy a position
of trust and confidence. The Executive shall not, except as may be required to
perform his duties hereunder or as required by applicable law, until the
expiration of the applicable periods described in Section 10(b) or until such
information shall have become public other than by the Executive's unauthorized
disclosure, disclose to others or use, whether directly or indirectly, any
Confidential Information regarding the Company, its subsidiaries and
affiliates. "Confidential Information" shall mean information about the
Company, its subsidiaries and affiliates, and their respective clients and
customers that is not publicly disclosed by the Company or otherwise generally
available to members of the public seeking such information and that was
learned by the Executive in the course of his employment by the Company, its
subsidiaries and affiliates, including (without limitation) any proprietary
knowledge, trade secrets, data, formulae, information and client and customer
lists and all papers, resumes, and records (including computer records) of the
documents containing such Confidential Information. The Executive acknowledges
that such Confidential Information is specialized, unique in nature and of
great value to the Company, its subsidiaries and affiliates, and that such
information gives the Company, its subsidiaries and affiliates a competitive
advantage. The Executive agrees to deliver or return to the Company, at the
Company's request at any time or upon termination or expiration of his
employment or as soon thereafter as possible, all documents, computer tapes and
disks, records, lists, data, drawings, prints, notes and written information
(and all copies thereof) furnished by the Company, its subsidiaries or
affiliates or prepared by the Executive during the
16
term of his employment by the Company, its subsidiaries and affiliates.
In the event that the Executive engages in any conduct proscribed by
this Section 11, the Executive agrees to repay any lump-sum severance amount
received pursuant to Section 5 of this Agreement, and all outstanding stock
options held by the Executive shall expire as of the date of the Executive's
commencement of such proscribed conduct. It is further expressly agreed that
the Company will or would suffer irreparable injury if Executive were to
disclose or threaten to disclose Confidential Information regarding the Company
or any subsidiary or affiliate in violation of this Agreement or otherwise fail
to comply with the provisions of this Section 11, and that the Company would,
by reason of such disclosure or threatened disclosure or other failure to
comply, be entitled to preliminary or permanent injunctive relief in a court of
appropriate jurisdiction, and Executive further consents and stipulates to the
entry of such preliminary or permanent injunctive relief in such a court
prohibiting Executive from disclosing Confidential Information in violation of
this Agreement or otherwise requiring Executive to comply with the provisions
of this Section 11 upon an appropriate finding by such court that Executive has
violated this Section 11.
12 NOTICE. For the purposes of this Agreement, any notices, demands and
all other communications required or permitted hereunder shall be in writing
and shall be deemed to have been duly given upon (a) transmitter's confirmation
of a receipt of a facsimile transmission, (b) confirmed delivery by a standard
overnight carrier or (c) the expiration of five business days after the day
when mailed by certified or registered mail, postage prepaid, addressed as
follows (or at such other address as the parties hereto shall specify by like
notice):
If to Executive: Charles R. Miller
c/o Paracelsus Healthcare Corporation
515 West Greens Road, Suite 800
Houston, Texas 77067
Telecopy No. (713) 873-6686
With a copy to: Wayne Whitaker
Michener, Larimore, Swindle, Whitaker, Flowers,
Sawyer, Reynolds & Chalk, L.L.P.
3500 City Center Tower II
301 Commerce Street
Fort Worth, Texas 76102-4135
Telecopy No.: (817) 335-6935
If to Company: Paracelsus Healthcare Corporation
515 West Greens Road
17
Suite 800
Houston, Texas 77067
Telecopy No. (713) 878-6686
Attention: Robert C. Joyner, Senior
Vice President and General Counsel
with a copy to: Skadden, Arps, Slate, Meagher & Flom
300 South Grand Avenue, Suite 3400
Los Angeles, California 990071
Telecopy No. (213) 687-5600
Attention: Thomas C. Janson
13. AMENDMENT, WAIVER. No provisions of this Agreement may be waived,
modified or discharged unless such waiver, modification or discharge is agreed
to in a written document signed by the Executive and such officer of the
Company, as may be specifically designated by the Board. No waiver by either
party hereto at any time of any breach by the other party hereto of, or
compliance with, any condition or provision of this Agreement to be performed
by such other party shall be deemed a waiver of similar or dissimilar
provisions or conditions at the same or at any prior or subsequent time. No
agreements or representations, oral or otherwise, express or implied, with
respect to the subject matter hereof have been made by either party which are
not set forth expressly in this Agreement.
14. ENTIRE AGREEMENT. This Agreement and Exhibits A and B hereto set
forth the entire agreement of the parties hereto in respect of the subject
matter contained herein and supersede all prior agreements, promises,
covenants, arrangements, communications, representations or warranties, whether
oral or written, by any officer, employee or representative of any party
hereto.
15. GOVERNING LAW; VENUE; VALIDITY. The interpretation, construction
and performance of this Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the State of Texas without
regard to the principle of conflicts of laws and, at the election of the
Executive, the venue of any dispute arising under this Agreement shall be
Texas. The invalidity or unenforceability of any provision of this Agreement
shall not affect the validity or enforceability of any other provision of this
Agreement, which other provisions shall remain in full force and effect.
16. HEADINGS. Section headings in this Agreement are included herein
for convenience of reference only and shall not constitute a part of this
Agreement for any other purpose.
17. SEVERABILITY. In the event that a court of competent jurisdiction
determines that any portion of this Agreement is in
18
violation of any statute or public policy, only the portions of this Agreement
that violate such statute or public policy shall be stricken. All portions of
this Agreement that do not violate any statute or public policy shall continue
in full force and effect. Further, any court order striking any portion of this
Agreement shall modify the stricken terms as narrowly as possible to give as
much effect as possible to the intentions of the parties under this Agreement.
19
IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date and year first written above.
PARACELSUS HEALTHCARE CORPORATION
By: \s\ R.J. MESSENGER
-------------------------------------
Name: R.J. Messenger
Title: Chief Executive Officer
\s\ CHARLES R. MILLER
-------------------------------------
Charles R. Miller
20
EXHIBIT A
MANAGEMENT RIGHTS TERMS
In so much as the Board of Directors and Dr. Manfred Krukemeyer recognize the
value to recruiting and retaining the services of a highly qualified executive
team and that such objective is in the best interests of the Company and all
its stockholders, and further that Messrs. Messenger, Miller, VanDevender and
Patterson are instrumental to insuring the success of the merger between
Paracelsus and Champion, and that a clear delineation of duties, authority and
responsibility is essential to the foregoing, the Board of Directors, Dr.
Krukemeyer, and Messrs. Messenger and Miller ("The Parties") agree that the
concepts set forth herein will be incorporated in the various merger
transaction documents, including employment contracts:
Board of Directors Authority and Responsibility - Ron Messenger and Charles
Miller shall have the authority to discharge their duties and responsibilities
as outlined herein for managing the affairs of the corporation except for those
items delineated below which is understood normally requires Board approval.
The Board, in its discretion, may delegate any such authority and approval
powers as it deems appropriate with respect to the items delineated below to
duly constituted committees of the Board excepting those powers and authority
which require the action of the Board acting as a whole.
1) Acquisitions & Divestitures of any kind
2) Capital expenditures exceeding $5 million per project ($10 million
for construction and/or renovation projects and acquisition of real estate) and
$50 million in aggregate, including but not limited to equipment purchases,
capitalized leases and acquisition of physician practices, clinic, surgery
center, or other healthcare entities
3) Major financings and any offerings of equity or debt
4) Issuance of stock
5) Appointment of corporate officers
6) Stock option plans or stock grants
7) Approval of annual operating and capital budget
8) Employment Agreements for Executive Management
9) Changes or amendments to corporate charter of incorporation or by-
laws
21
10) Material change in Company business strategy
11) Liquidation or sale of Company or any subsidiary or merger or other
business combination with another company
12) Compensation and benefit levels and incentive plans for executive
officers
13) Termination of the: (i) CEO, (ii) President and COO, (iii) CFO
The Board shall designate an Executive Committee of the Board which shall be
delegated such authority as decided by the Board of Directors for conducting
the business of the Company. Members of the Executive Committee shall be: (i)
Mr. Messenger, as Chairman, (ii) Mr. Miller, and (iii) Mr. VanDevender. The
Executive Committee shall be delegated the authority to act on behalf of the
Board on any business issues not otherwise requiring action by the Board as a
whole except:
1) Major financings and any offerings of equity or debt
2) Issuance of stock or approval of stock option plans
3) Employment Agreements for (i) CEO, (ii) President & COO, and (iii)
CFO
4) Compensation, benefits and incentive plans, including allocation of
stock options for (i) CEO, (ii) President & COO, and (iii) CFO
5) Termination of (i) CEO, (ii) President & COO, and (iii) CFO
6) Material change in Company business strategy
7) Changes or amendments to the corporate charter of incorporation or
by-laws
8) Liquidation or sale of Company or subsidiary or merger or other
business combination with another company
9) Any hospital acquisition transaction involving more than a $30
million expenditure of capital, excluding working capital and/or assumption of
debt
10) Divestiture of any hospital
11) Approval of annual operating and capital budget
22
12) Capital expenditures exceeding $5 million per project ($10 million
for construction and/or renovation projects and acquisition of real estate) and
$50 million in aggregate, including but not limited to equipment purchases,
capitalized leases and acquisition of physician practices, clinic, surgery
center, or other healthcare entities
MR. MESSENGER AUTHORITY AND RESPONSIBILITY - The parties agree that Mr.
Messenger shall be Chairman of The Executive Committee of the Board of
Directors and serve as Chief Executive Officer of the new company. Except
where otherwise noted, decisions with respect to the following shall be
reserved exclusively to Mr. Messenger at his sole discretion:
1) serving as liaison with Board of Directors
2) Relocation of corporate offices
3) Capital expenditures, as defined above, which exceed $3 million and
up to $5,000,000
4) Employment and compensation status of direct reports to Mr. Messenger
(as defined throughout this agreement, references to Messenger "direct reports"
shall exclude Mr. Miller)
5) Approval of senior lender participants and agent bank
6) Approval of investment bankers, upon concurrence by Mr. Miller
7) Chairmanship of the Executive Committee of the Board of Directors
Any and all proposals to be presented to the Board, or any of its Committees,
or the Executive Committee are subject to the review of and approval,
disapproval or modification by Mr. Messenger.
Mr. Messenger, in his sole discretion and to the extent practicable, may elect
to exempt himself, and his direct reports from any changes in corporate
policies and procedures which: (i) were not agreed to at the time of the
merger, or (ii) reduce or materially affect the agreed upon status or benefits
of Mr. Messenger or his direct reports.
Mr. Messenger shall develop and be solely responsible for administering and
controlling an overhead budget for the Office of the CEO which shall include
himself and his direct reports with such budget subject to the approval by the
Board of Directors, provided however that such budget does not otherwise breach
or circumvent Mr. Miller's authority and responsibility as set forth herein.
23
Any other duties, authority and responsibilities not delineated above, or which
are not otherwise reserved specifically to the Board or Mr. Miller, shall be
reserved to Mr. Messenger so long as such duties, authority and
responsibilities do not otherwise unreasonably abridge Mr. Miller's rights to
manage the day-to-day affairs of the new Company as delineated below.
MR. MILLER AUTHORITY AND RESPONSIBILITY - The parties have agreed that it is in
the best interests of the Company and its stockholders to retain Mr. Miller's
services following the merger and that he shall be elected President and Chief
Operating Officer of the new company and, along with Mr. VanDevender, be
appointed to the Executive Committee of the Board. The parties also agree that
Mr. Miller shall be delegated full authority and responsibility for managing
the day-to-day affairs of the corporation, subject to the powers and authority
reserved exclusively to the Board of Directors and Mr. Messenger as delineated
above and the mutual areas of responsibility to be shared by Messrs. Messenger
and Miller delineated below. Therefore, the parties agree that Mr. Charles R.
Miller in his sole discretion shall have such authority and responsibility as
is reasonably required to manage and oversee the day-to-day affairs of the
corporation, including but not limited to the following:
1) HOSPITAL, SUBSIDIARY AND BUSINESS UNITS - Complete responsibility for
management and decisions associated with the operations of the Company's
hospitals, business units, subsidiaries and markets, including but not limited
to: (i) determination of staffing levels, (ii) control of expenses, (iii)
recruitment, selection and employment of key management, (iv) management and
financial reporting and systems, including data processing systems, (v) medical
staff issues, including credentialing and modifications to and enforcement of
medical staff by-laws, rules and regulations, (vi) quality of care and service,
(vii) decisions regarding programs and services to be offered or discontinued,
(viii) use or discontinuance of vendors, contractors and consultants, (ix) any
and all contracts and the approval, discontinuance or modification thereof,
including physician contracts, (x) accounting, budgeting, reimbursement,
financial and cash management policies, procedures and systems, (xi) market
strategy development and implementation, (xii) composition of local boards,
(xiii) policies, by-laws, rules & regulations, (xiv) promotional and marketing
activities, and (xv) capital expenditures up to but not exceeding $3 million.
2) CONTRACTS AND LEASES - Approval or disapproval of any and all
contracts and leases within Mr. Miller's authority level.
3) CORPORATE OVERHEAD BUDGET & EXPENSES - Complete authority for
development, control, administration and management of the
24
Company's corporate overhead budget, after approved by Board, and control of
all corporate expenses, excluding the CEO's direct reports and corporate
overhead budget.
4) CORPORATE MATTERS - Management and supervision of the Company's
corporate activities and operations (excluding Mr. Messenger's direct reports
and corporate overhead budget), responsibility for all decisions pertaining
thereto, including but not limited to, (i) establishing or changing of job
titles, duties and responsibilities, (ii) recruiting, hiring, firing,
promoting, demoting, transferring, and relocating employees, (iii) determining
compensation levels, incentive plans, and benefit programs, (iv) establishment,
revision or discontinuance of Company policies and procedures, (v) legal
affairs and related matters, including risk management and insurance, (vi)
budgeting, data processing, tax, fiscal, accounting, reimbursement, cash
management and corporate finance, including policies, procedures and systems,
(vii) management and financial reporting policies, procedures and systems,
(viii) construction and renovation projects, (ix) managed care contracting, (x)
acquisition and development activities, (xi) physician recruiting and
associated physician activities such as practice management, (xii) development
and execution of Company business plan and strategies, (xiii) press releases,
public relations, and media relations, (xiv) preparation of the Company's
annual operating and capital budget, and (xv) investor and banking relations
(except as noted below under "Mutual Responsibility").
The parties agree that any duties, responsibilities, functions, or authority
not specifically delineated in this section but which would otherwise
reasonably be considered integral to managing the day-to-day affairs of the
Company and its operations, including its business units, subsidiaries and
affiliates, both now and in the future, will be reserved to Mr. Miller as part
of this Management Rights Agreement.
MUTUAL RESPONSIBILITY - Messrs. Messenger and Miller agree to jointly develop
plans and strategies for promoting the Company to the financial community,
including but not limited to: (i) preparation of the annual report, (ii)
analyst meetings, (iii) road shows, (iv) presentations at conferences, (v) bank
meetings and presentations, (vi) mergers, acquisitions, and divestitures, and
(vii) media interviews.
Further, Messrs. Messenger and Miller will be considered "ex-officio" members
of any and all boards of the new company's subsidiary operations and may elect
to attend any meetings of such boards at their sole discretion.
COVENANT NOT TO BREACH AGREEMENT - The Board of Directors, Dr. Krukemeyer and
Mr. Messenger agree not to initiate any actions or
25
decisions which in any way would breach Mr. Miller's duties, authority and
responsibility as specified herein, except where the Board's authority or
approval is otherwise required. The Board and Dr. Krukemeyer further agree not
to initiate any actions or decisions which in any way breach Mr. Messenger's
duties, authority and responsibility as specified herein, except where the
Board's authority or approval is otherwise required.
The parties agree that any breach of the above duties, authority and
responsibility of Messrs. Miller and Messenger shall constructively constitute
Termination Without Cause as specified in Messrs. Messenger's and Miller's
Employment Agreements, unless such breach is waived in writing by Messrs.
Messenger and Miller.
These "Management Rights Terms" shall be incorporated into the Employment
Contracts of Messrs. Messenger and Miller and/or such other documents as is
appropriate and shall be in full force and effect through each contract renewal
term of Messrs. Messenger and Miller until Mr. Miller shall become CEO of the
Company.
26
EXHIBIT B
During the Term of the Agreement, the Company shall provide Executive with
the following life insurance and disability coverages:
(1) The Company shall maintain for Executive's benefit life insurance
coverage with a face amount equal to three (3) times the amount of Executive's
Base Salary as in effect from time to time; PROVIDED, HOWEVER, that if the
Company shall be unable to obtain the full amount of such life insurance
coverage at a reasonable cost, the Company may alternatively provide Executive
with a lump-sum death benefit, payable within ninety (90) days following the
date of Executive's death, in such amount as will, when added to any life
insurance coverage actually obtained by the Company, provide Executive's
beneficiary(ies) with a net amount, after payment of any Federal and state
income taxes, equal to the net, after-tax amount such beneficiary(ies) would
have received had the Company obtained the full amount of life insurance
coverage provided for above. The Executive shall have the right to name and to
change from time to time the beneficiary(ies) under such life insurance
coverage (and death benefits, if any). Such life insurance coverage (and death
benefit, if any) shall be in addition to any death benefits which may be
payable under any accidental death and dismemberment plan, any separate
business travel accident coverage, or any pension plan in which the Executive
may participate, and such coverage shall also be in addition to any life
insurance which Executive himself purchases.
(2) LONG-TERM DISABILITY - In the event the Executive becomes disabled
(as defined in the long-term disability plan presently maintained by the
Company), the Executive is to receive the disability benefits in an amount
equal to 60% of his then salary. Any amount payable under any salary
continuation plan (including any salary continuation provided under this
agreement) or disability plan maintained by the Company, and any amount payable
as a Social Security disability benefit or similar benefit to Executive or his
immediate family shall be counted towards the Company's fulfillment of such
obligation. Disability benefits will be payable monthly commencing thirty (30)
days following disability and will continue until Executive is no longer
disabled or, if earlier, until he reaches age 65.
During the Term of the Agreement, the Company shall also provide Executive
with the following additional fringe benefits:
1) VACATIONS AND HOLIDAYS - Executive shall be entitled to such paid
vacation time as may be reasonably taken at Executive's discretion so long as
such vacation time does not interfere with the efficient discharge of the
Executive's duties and responsibilities. Executive shall be entitled to all
holidays as delineated annually in the Company's official holiday schedule
27
2) TAX RETURN PREPARATION ASSISTANCE; FINANCIAL ADVICE - will provide
the Executive with the assistance of the Company's regular auditors for the
preparation of Executive's United States Federal and State tax returns without
charge to Executive. In addition, the Company shall reimburse Executive for
the costs incurred by Executive for financial planning services in an amount
not to exceed $5,000 annually.
3) ANNUAL PHYSICAL EXAMINATION - The Company shall reimburse Executive
100% of all costs incurred by Executive in obtaining an annual comprehensive
physical examination to be conducted by a physician; clinic, or medical group
of the Executive's choice and which is located within reasonable proximity to
Executive's place of Employment
28
FIRST AMENDMENT TO PARACELSUS HEALTHCARE CORPORATION
EMPLOYMENT AGREEMENT
THIS FIRST AMENDMENT TO PARACELSUS HEALTHCARE CORPORATION EMPLOYMENT AGREEMENT,
dated as of July 17, 1996, between Paracelsus Healthcare Corporation, a
California corporation (the "Company") and Charles R. Miller (the "Executive")
RECITALS:
WHEREAS, the Company and the Executive entered into that certain
Paracelsus Healthcare Corporation Employment Agreement dated as of July 17,
1996, (the "Employment Agreement"), and
WHEREAS, the parties desire to amend the Employment Agreement to clearly
reflect that Executive will not be forced to relocate.
AGREEMENT
NOW THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged by each party, the parties
intending to be legally bound hereby agree as follows:
1. Paragraph 4(iii)(D) is hereby deleted in its entirety, and the
following is added in its place:
"(D) The Constructive Relocation of Executive, defined as (I)
reassignment of the executive, (II) relocation of the principal executive
offices of the Company, or (iii) assignment of duties, such that any of the
foregoing, either individually or in combination would require Executive to
either (a) effectively relocate Executive's primary residence or (b) increase
Executive's one-way commute by more than 25 miles from Executive's current
primary residence."
2. All other terms and conditions not changed hereby shall remain in
full force and effect.
29
IN WITNESS WHEREOF, the parties have executed this First Amendment to
Paracelsus Healthcare Corporation Employment Agreement as of the date and year
first written above.
PARACELSUS HEALTHCARE CORPORATION
By: \s\ R.J. MESSENGER
-------------------------------------
Name: R.J. Messenger
Title: Chief Executive Officer
\s\ CHARLES R. MILLER
-------------------------------------
Charles R. Miller